Evidence map›Paper›PMID 24808640›Full record

ArticleMediators of inflammation2014

A polymorphism of ORAI1 rs7135617, is associated with susceptibility to rheumatoid arthritis.

Jeng-Hsien Yen, Che-Mai Chang, Yu-Wen Hsu, Chih-Hung Lee, Mei-Shin Wu, Daw-Yang Hwang, Ben-Kuen Chen, Hsien-Tzung Liao, Man-Tzu Marcie Wu, Wei-Chiao Chang

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Immunogenetics of Kawasaki disease.Clinical reviews in allergy & immunology · 2020
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. rs2841277 (Oncotarget · 2017
    Article
  10. Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jeng-Hsien YenCollege of Medicine, Kaohsiung Medical University, and Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 83301, Taiwan.
Che-Mai ChangDepartment of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Yu-Wen HsuDepartment of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Chih-Hung LeeDepartment of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan ; Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.
Mei-Shin WuDepartment of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Daw-Yang HwangDivision of Nephrology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Ben-Kuen ChenInstitute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan 701, Taiwan.
Hsien-Tzung LiaoDivision of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University-Wan Fang Hospital, Taipei 11696, Taiwan ; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11696, Taiwan.
Man-Tzu Marcie WuDepartment of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan ; Department of Pharmacy, Taipei Medical University-Wan Fang Hospital, Taipei 11696, Taiwan.
Wei-Chiao ChangDepartment of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan ; Department of Pharmacy, Taipei Medical University-Wan Fang Hospital, Taipei 11696, Taiwan ; Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan ; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Taipei Medical University · TWKaohsiung Medical University Chung-Ho Memorial Hospital · TWWan Fang Hospital · TWChang Gung University · TWNational Cheng Kung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA), a chronic inflammatory disease usually occurring in synovial tissues and joints, is highly associated with genetic and environmental factors. ORAI1, a gene related to cellular immune system, has been shown to be involved in the pathogenesis of chronic inflammatory diseases and immune diseases. To identify whether ORAI1 gene contributes to RA susceptibility, we enrolled 400 patients with RA and 621 healthy individuals for a case-control genetic association study. Five tagging single nucleotides polymorphisms (tSPNs) within ORAI1 gene were selected for genotyping. An SNP, rs7135617, showed a significant correlation with the risk of RA. Our results indicated that genetic polymorphism of ORAI1 gene is involved in the susceptibility of RA in a Taiwanese population.

Indexed as

AdolescentAdultAgedAged, 80 and overArthritis, RheumatoidCalcium ChannelsCase-Control StudiesChildFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedORAI1 ProteinPolymorphism, Single NucleotideYoung AdultCalcium ChannelsORAI1 ProteinORAI1 protein, human

Identifiers

PMID24808640
PMCPMC3997980
OpenAlexW2046346526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.